We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nuvo Pharmaceuticals Inc | TSX:MRV | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.34 | 1.35 | 0 | 01:00:00 |
- Tuesday, May 18th – 2:00 p.m. ET -
MISSISSAUGA, ON, May 11, 2021 /PRNewswire/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Miravo's President & Chief Executive Officer and Mary-Jane Burkett, Miravo's Vice President & Chief Financial Officer will be presenting at the Q2 Virtual Investor Summit.
DATE: | Tuesday, May 18,, 2021 |
TIME: | 2:00 p.m. ET |
COMPLIMENTARY | https://zoom.us/webinar/register/WN_KHDIM1GmQi6On6OA6gAZ6w |
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.
Please visit the website at www.investorsummitgroup.com
About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company's products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company's manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-present-at-q2-virtual-investor-summit-301288267.html
SOURCE Nuvo Pharmaceuticals Inc.
Copyright 2021 PR Newswire
1 Year Nuvo Pharmaceuticals Chart |
1 Month Nuvo Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions